share_log

Phio Pharmaceuticals To Present Data On INSTAYL Compound PH-894 At ASGCT's 2024 Cancer Conference; PH-894 Shows Potent Silencing Of BRD4 In NK Cells, Enhances NK Cell Proliferation And Cytotoxicity

Benzinga ·  Oct 16 20:25
Phio Pharmaceuticals To Present Data On INSTAYL Compound PH-894 At ASGCT's 2024 Cancer Conference; PH-894 Shows Potent Silencing Of BRD4 In NK Cells, Enhances NK Cell Proliferation And Cytotoxicity
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment